From US$ 6.84 Billion to US$ 11.29 Billion: The Future of the Dry Eye Disease Market
The Dry Eye Disease is witnessing substantial growth as the prevalence of ocular surface disorders continues to increase worldwide. Pharmaceutical companies are investing significantly in the development of innovative formulations, biologics, and long-acting therapies to address the unmet needs of patients suffering from chronic dry eye conditions. Market Trends and Growth Analysis According to...
0 Kommentare 0 Geteilt 143 Ansichten 0 Bewertungen